Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Frederick C Smith Clinic dba Smith Clinic
mi
from
Marion, OH
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Frederick C Smith Clinic dba Smith Clinic
mi
from
Marion, OH
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Oregon Health and Sciences University Hospital
mi
from
Portland, OR
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Oregon Health and Sciences University Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Pinnacle Health Hospital
mi
from
Harrisburg, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Pinnacle Health Hospital
mi
from
Harrisburg, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
York Hospital
mi
from
York, PA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Miriam Hospital
mi
from
Providence, RI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
AnMed Health
mi
from
Anderson, SC
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Black Hills Research- Rapid City Regional
mi
from
Rapid City, SD
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Black Hills Research- Rapid City Regional
mi
from
Rapid City, SD
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Chattanooga Heart - East Third Street
mi
from
Chattanooga, TN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Chattanooga Heart - East Third Street
mi
from
Chattanooga, TN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Centennial Heart Medical Center
mi
from
Nashville, TN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Centennial Heart Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Austin Heart, P.A.
mi
from
Austin, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Austin Heart, P.A.
mi
from
Austin, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Veterans Affairs Medical Center - Dallas
mi
from
Dallas, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Veterans Affairs Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Methodist DeBakey Heart & Vascular Center
mi
from
Houston, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Methodist DeBakey Heart & Vascular Center
mi
from
Houston, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
North Dallas Research Associates
mi
from
McKinney, TX
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
North Dallas Research Associates
mi
from
McKinney, TX
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Univ of Washington
mi
from
Seattle, WA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Sacred Heart Medical Center
mi
from
Spokane, WA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Vincents Hospital Sydney
mi
from
Darlinghurst,
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Vincents Hospital Sydney
mi
from
Darlinghurst,
Click here to add this to my saved trials
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Status: Enrolling
Updated:  9/18/2015
University of Toledo
mi
from
Toledo, OH
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Status: Enrolling
Updated: 9/18/2015
University of Toledo
mi
from
Toledo, OH
Click here to add this to my saved trials
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Status: Enrolling
Updated:  9/21/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Status: Enrolling
Updated: 9/21/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study
Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study
Status: Enrolling
Updated:  9/22/2015
Massachusetts General Hospital
mi
from
Boston, MA
Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study
Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study
Status: Enrolling
Updated: 9/22/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Left Versus Right Radial Artery and Radiation Exposure in Patients With Predictors of Trans-radial Failure
Effect of Left Versus Right Radial Artery Access on Radiation Exposure in Patients With Predictors of Potential Trans-radial Access Failure
Status: Enrolling
Updated:  9/22/2015
New York University Langone Medical Center
mi
from
New York, NY
Left Versus Right Radial Artery and Radiation Exposure in Patients With Predictors of Trans-radial Failure
Effect of Left Versus Right Radial Artery Access on Radiation Exposure in Patients With Predictors of Potential Trans-radial Access Failure
Status: Enrolling
Updated: 9/22/2015
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
Phase IIb Study Comparing Tenecteplase to Alteplase in Acute Ischemic Stroke Within 3 to 4.5 Hours From Symptom Onset
Status: Enrolling
Updated:  9/22/2015
The Ohio State University College of Medicine
mi
from
Columbus, OH
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
Phase IIb Study Comparing Tenecteplase to Alteplase in Acute Ischemic Stroke Within 3 to 4.5 Hours From Symptom Onset
Status: Enrolling
Updated: 9/22/2015
The Ohio State University College of Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
Feasibility Study of IV rtPA vs. Primary Endovascular Therapy for Acute Ischemic Stroke
Endovascular Arterial Reperfusion vs. Intravenous ThromboLYsis for Acute Ischemic Stroke (EARLY): A Randomized Pilot Study of Ultra-early (<2 Hours) and Early (2-4.5 Hours) Reperfusion Therapy
Status: Enrolling
Updated:  9/23/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Feasibility Study of IV rtPA vs. Primary Endovascular Therapy for Acute Ischemic Stroke
Endovascular Arterial Reperfusion vs. Intravenous ThromboLYsis for Acute Ischemic Stroke (EARLY): A Randomized Pilot Study of Ultra-early (<2 Hours) and Early (2-4.5 Hours) Reperfusion Therapy
Status: Enrolling
Updated: 9/23/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Magnetic Resonance Imaging of the Blood Vessels of the Heart
Cardiovascular Magnetic Resonance Imaging
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy
Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy
Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Evaluation of Patients With Known or Suspected Heart Disease
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Abnormal Blood Clotting in Children With Stroke
Study of Abnormal Acquired and Genetic Coagulation Factors in Children With Porencephaly and Stroke
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Study of Abnormal Blood Clotting in Children With Stroke
Study of Abnormal Acquired and Genetic Coagulation Factors in Children With Porencephaly and Stroke
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting
Assessing the Risk of New Ischemic Brain Lesions With On- Versus Off-Pump Coronary Artery Bypass Grafting
Status: Enrolling
Updated:  9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting
Assessing the Risk of New Ischemic Brain Lesions With On- Versus Off-Pump Coronary Artery Bypass Grafting
Status: Enrolling
Updated: 9/26/2015
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
The Framingham Study: Examining DNA Markers and Links to Diseases
A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
The Framingham Study: Examining DNA Markers and Links to Diseases
A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated:  9/26/2015
Baptist Health System, Inc.
mi
from
Birmingham, AL
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated: 9/26/2015
Baptist Health System, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated:  9/26/2015
University of Wisconsin
mi
from
Madison, WI
EW-A-401 to Treat Intermittent Claudication
Modulation of Vascular Endothelial Growth Factor (VEGF) Using an Engineered Zinc-Finger Transcription Factor to Treat Lower Limb Intermittent Claudication
Status: Enrolling
Updated: 9/26/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the Legs
Real-Time MRI-Guided Percutaneous Intervention for Aorto-illac and Femoropopliteal, Artery Stenosis
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the Legs
Real-Time MRI-Guided Percutaneous Intervention for Aorto-illac and Femoropopliteal, Artery Stenosis
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Biomarkers for Cardiovascular Disease
Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients With Coronary Artery Disease
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Biomarkers for Cardiovascular Disease
Nitrite as a Marker of Cardiovascular Risk; Development of Novel Biomarkers in Patients With Coronary Artery Disease
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
Dose-Response Study of Modulation of Gene Expression in Peripheral Blood Mononuclear Cells by Atorvastatin
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated:  9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated: 9/26/2015
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients With Coronary Artery Disease Undergoing Cardiac Rehabilitation
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis
Prospective Study of Inflammatory Markers and Genes as Predictors of Atherosclerotic Cardiovascular Disease in Dialysis Patients
Status: Enrolling
Updated:  9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis
Prospective Study of Inflammatory Markers and Genes as Predictors of Atherosclerotic Cardiovascular Disease in Dialysis Patients
Status: Enrolling
Updated: 9/26/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Genetic Analysis of Left-Right Axis Formations
Genetic Analysis of Left-Right Axis Malformations
Status: Enrolling
Updated:  9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic Analysis of Left-Right Axis Formations
Genetic Analysis of Left-Right Axis Malformations
Status: Enrolling
Updated: 9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Catheter-Based Treatment of Cardiovascular Disease
Catheter-Based Treatment of Cardiovascular Disease in Patients
Status: Enrolling
Updated:  9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Catheter-Based Treatment of Cardiovascular Disease
Catheter-Based Treatment of Cardiovascular Disease in Patients
Status: Enrolling
Updated: 9/26/2015
National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Validation of MRI Measurement of Cardiac Blood Flow
Validation of Cardiac MR Perfusion With Cardiac Catheterization Physiological Assessment
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Validation of MRI Measurement of Cardiac Blood Flow
Validation of Cardiac MR Perfusion With Cardiac Catheterization Physiological Assessment
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Imaging of Totally Blocked Arteries
Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Imaging of Totally Blocked Arteries
Gadofosveset Imaging of Chronic Total Peripheral Artery Occlusion (CTO)
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Roles of Trust and Respect in Patient Reactions to Race-based and Personalized Medicine Vignettes: An Experimental Study
The Roles of Trust and Respect in Patient Reactions to Race-Based and Personalized Medicine Vignettes: An Experimental Study
Status: Enrolling
Updated:  9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
The Roles of Trust and Respect in Patient Reactions to Race-based and Personalized Medicine Vignettes: An Experimental Study
The Roles of Trust and Respect in Patient Reactions to Race-Based and Personalized Medicine Vignettes: An Experimental Study
Status: Enrolling
Updated: 9/26/2015
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Improving Prevention of Heart Disease in Latinos
Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk
Status: Enrolling
Updated:  9/29/2015
Denver Health Medical Center
mi
from
Denver, CO
Improving Prevention of Heart Disease in Latinos
Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk
Status: Enrolling
Updated: 9/29/2015
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials